Medical and scientific research workers in industry, academia and hospitals need human tissue samples for their research programmes. Many bioscientists have tried to achieve this by establishing a direct relationship with a surgeon or a pathologist at a local hospital. In many cases, the supply is unreliable and, consequently, the progress of good research has been frustrated. 1 The recent controversy involving staff working at the Alder Hey and Bristol Hospitals has shown that the consent of the next of kin to use non-transplantable organs and tissues for medical research has not always been obtained. It is highly likely that this practice has occurred at other hospitals throughout the UK.
Donations of cadaveric organs and tissues are accompanied by relevant medical information and results of virological testing. Even where donated human tissue is stated to be HIV1 or HIV2 negative and Hepatitis B and C negative, research workers receiving samples of this tissue are advised to treat all tissue as biohazardous. Tissue donated from living patients undergoing elective surgery cannot be tested for HIV1 or HIV2 without the patient's prior informed consent. It is, therefore, the duty of staff operating a tissue banking service to ensure that ethically approved recipients of donated human tissue work according to government-recommended safety standards within properly equipped scientific laboratories.
A computerised and manual tissue-management system of recording and auditing the collection, processing, storage and distribution of human tissue samples can ensure that the use and eventual disposal of all samples can be traced at any time.
Providing these conditions are observed, I believe that it is now time to make it possible for ethically approved bioscientific institutions to have access to supplies of a wide range of human tissues that will enable research programmes to be planned and carried out more efficiently. The whole process of procurement, processing, storage and equitable distribution of non-transplantable human organs and tissues for research deserves the dignity of official government recognition.
In the UK, the Human Tissue Act 1961 2 permits the procurement of non-transplantable human organs and tissues for medical research and education. The report of the Nuffield Council on Bioethics, published in April 1995, 3 highlighted several important points concerning human tissue use in biomedical research. It recommended strict adherence to three important ethical principles.
1. Non-profitability when processing and distributing donated human tissue (transparency and probity).
2. Informed/genuine consent obtained prior to procurement of human tissue for research purposes.
3. Confidentiality, i.e. the anonymisation of all hospital and patient records.
The Nuffield Report also recommended that this service should be conducted by suitably qualified "intermediaries", thus separating the donating centres from hospital medical researchers and scientists working within commercial bioscientific institutions. Qualified intermediaries operating a human tissue bank can also ensure that the movement and disposal of human tissue can be traced at any time.
Editorial
The need for human tissue models in biomedical experimentation is increasing rapidly. Research workers are aware of the need to reduce, refine and replace the use of animals/animal tissues in their experiments. There are numerous references in the scientific literature that illustrate that it is difficult enough to extrapolate from data obtained from in vitro experiments on animal tissues to the in vivo animal situation; it is even more unreliable to extrapolate to the in vivo human situation. A Department of Health-registered human tissue bank that has obtained multiregional medical ethical approval for all laboratory and administrative protocols will also have achieved registered charity status. A properly constituted organisation of this kind, overseen by a board of governors, and having an independent ethical advisory board, is surely best placed to procure and distribute donations of human tissue. This could eliminate the need for researchers working in hospitals or bioscientific institutions to spend time and effort searching for sources of human material. The Department of Health is examining this issue at present. It is therefore possible that the UK will become the first country in Europe officially to support this type of important service to industrial scientists and academics.
It is important that biomedical researchers have access to a safe, reliable and ethical service of this kind, where the movement of tissue can be audited. It is of equal importance that feedback concerning the type of biomedical research supported by each donation is given to transplant coordinators and other health professionals. Should the donor's family request this information, it should be given to them in an appropriate form.
This type of regulated human tissue banking service can operate without risk of detriment to the national organ-transplant programme, and must be in the long-term interests of the National Health Service.
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